Works matching IS 21660166 AND DT 2015 AND VI 4 AND IP 2
Results: 10
President Obama's Bet on Personalized Medicine.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 122
- By:
- Publication type:
- Article
What Is a Navigator?
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 120
- By:
- Publication type:
- Article
No Role for Adjuvant Sorafenib or Sunitinib in Locally Advanced Kidney Cancer.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 118
- By:
- Publication type:
- Article
AR-V7 Predicts Chemotherapy Sensitivity in Metastatic Prostate Cancer.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 117
- By:
- Publication type:
- Article
A Focus on Melanoma, Basal-Cell Carcinoma, Cutaneous T-Cell Lymphoma, Merkel-Cell Carcinoma, and Rare Cutaneous Malignancies: Highlights from the Third Annual World Cutaneous Malignancies Congress.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 104
- By:
- Publication type:
- Article
Cabozantinib in Prostate Cancer Patients with Bone Metastasis.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 95
- By:
- Publication type:
- Article
Biomarkers of the mTOR Pathway in Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 89
- By:
- Publication type:
- Article
Two Cases of Triple-Hit Lymphoma: A Call for Imperative MYC, BCL2, and BCL6 Testing by FISH in Aggressive Lymphomas.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 84
- By:
- Publication type:
- Article
The Ultimate Target of Personalized Oncology Treatment: Improving the Lives of Our Patients.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 72
- By:
- Publication type:
- Article
Confirming Diagnoses and Identifying Biomarkers Linked to Targeted Treatments with the bioT3 Approach.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 74
- By:
- Publication type:
- Article